©The Author(s) 2025.
World J Psychiatry. Dec 19, 2025; 15(12): 109437
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.109437
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.109437
Table 2 Medication use and adherence stratified by depression severity, % (n/total)
| Variables | No/mild depression (n = 100) | Moderate/severe depression (n = 60) | Test statistic | P value |
| β-blocker use | 68.0 (68/100) | 53.3 (32/60) | χ2 = 3.5 | 0.061 |
| ACE inhibitor/ARB use | 70.0 (70/100) | 56.7 (34/60) | χ2 = 3.7 | 0.054 |
| Diuretic use | 75.0 (75/100) | 61.7 (37/60) | χ2 = 3.0 | 0.084 |
| Antidepressant use | 9.0 (9/100) | 16.7 (10/60) | χ2 = 2.6 | 0.107 |
| Anxiolytic use | 7.0 (7/100) | 13.3 (8/60) | χ2 = 2.9 | 0.091 |
| Psychotherapy | 6.0 (6/100) | 18.3 (11/60) | χ2 = 4.1 | 0.043 |
| High adherence (MMAS-4 = 0) | 40.0 (40/100) | 25.0 (15/60) | χ2 = 4.6 | 0.031 |
| Moderate adherence (MMAS-4 = 1-2) | 38.0 (38/100) | 40.0 (24/60) | χ2 = 0.1 | 0.794 |
| Low adherence (MMAS-4 = 3-4) | 22.0 (22/100) | 35.0 (21/60) | χ2 = 3.9 | 0.048 |
- Citation: Mao FG, Tang YL, Wang XY, Jin X, Fan JY. Psychocardiological impact of depression on medication adherence, ventricular function, and readmission in heart failure: A retrospective cohort study. World J Psychiatry 2025; 15(12): 109437
- URL: https://www.wjgnet.com/2220-3206/full/v15/i12/109437.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i12.109437